Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM) Jun 2, 2026 06:50AM
Tempus receives FDA approval for tumor-only xT CDx genomic test May 29, 2026 08:15AM
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio May 29, 2026 08:15AM
Tempus Reports First Quarter 2026 Results May 5, 2026 04:01PM
Tempus to Host Inaugural Investor Day on May 29, 2026 Apr 29, 2026 08:30AM


Apr 21, 2026 08:30AM Tempus to Report First Quarter 2026 Financial Results on May 5
Apr 8, 2026 04:01PM Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
Feb 24, 2026 04:01PM Tempus Reports Fourth Quarter and Full Year 2025 Results
Feb 10, 2026 08:30AM Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
Jan 12, 2026 04:07AM Tempus AI reports record contract value exceeding $1.1 billion
Jan 11, 2026 05:30PM Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
Nov 25, 2025 06:14AM Tempus AI Inc (TEM) PT Raised to $105 at BTIG
Nov 18, 2025 08:30AM Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
Nov 4, 2025 04:01PM Tempus Reports Third Quarter 2025 Results
Oct 28, 2025 08:30AM Tempus to Participate in the Stifel 2025 Healthcare Conference
Oct 21, 2025 08:30AM Tempus to Report Third Quarter 2025 Financial Results on November 4
Sep 3, 2025 04:01PM Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference
Aug 8, 2025 06:00AM Tempus Reports Second Quarter 2025 Results
Jul 22, 2025 08:30AM Tempus to Report Second Quarter 2025 Financial Results on August 8
Jun 17, 2025 08:30AM Tempus to Participate in TD Cowen’s 4th Annual Tools/Dx Revolution Conference
May 21, 2025 08:30AM Tempus to Present at the William Blair 45th Annual Growth Stock Conference
May 6, 2025 04:01PM Tempus Reports First Quarter 2025 Results
Apr 24, 2025 08:30AM Tempus to Report First Quarter 2025 Financial Results on May 6
Mar 26, 2025 08:30AM Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference
Feb 24, 2025 04:01PM Tempus Reports Fourth Quarter and Full Year 2024 Results
Feb 19, 2025 08:30AM Tempus to Present at TD Cowen's 45th Annual Health Care Conference
Feb 18, 2025 04:50PM Ares Management (ARES) provides Tempus with total debt package of $560 million
Feb 18, 2025 04:30PM Ares Management Upsizes Tempus Debt Facilities to $560 Million
Feb 11, 2025 08:30AM Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
Nov 4, 2024 04:01PM Tempus AI (TEM) to Acquire Ambry Genetics, Reports Q3
Nov 4, 2024 04:01PM Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics
Nov 3, 2024 08:06PM Tempus to Report Third Quarter 2024 Financial Results on November 4
Oct 24, 2024 08:30AM Tempus to Report Third Quarter 2024 Financial Results on November 7
Aug 6, 2024 04:01PM Tempus Reports Second Quarter 2024 Results
Jul 17, 2024 09:30AM Tempus to Report Second Quarter 2024 Financial Results on August 6